Willem Adriaan de Jongh
Fundador en ExpreS2ion Biotechnologies ApS .
Perfil
Willem Adriaan de Jongh is the founder of ExpreS2ion Biotechnologies ApS, founded in 2009, where he holds the title of Chief Scientific Officer.
He was also the founder of Expres2ion Biotech Holding AB, founded in 2010, where he held the title of Chief Scientific Officer until 2020.
Currently, he is the Chief Executive Officer & Director at Adaptvac ApS since 2017.
Dr. de Jongh received his doctorate degree from the Technical University of Denmark in 2006 and his undergraduate and graduate degrees from the University of Stellenbosch.
Cargos activos de Willem Adriaan de Jongh
| Empresas | Cargo | Inicio |
|---|---|---|
ExpreS2ion Biotechnologies ApS
 ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Fundador | 01/01/2009 |
| Adaptvac ApS | Director Ejecutivo | 01/01/2017 |
Antiguos cargos conocidos de Willem Adriaan de Jongh.
| Empresas | Cargo | Fin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Fundador | 01/12/2020 |
Formación de Willem Adriaan de Jongh.
| Technical University of Denmark | Doctorate Degree |
| University of Stellenbosch | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Health Technology |
| Empresas privadas | 2 |
|---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark. | Health Technology |
| Adaptvac ApS |
- Bolsa de valores
- Insiders
- Willem Adriaan de Jongh
